Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Biochim Biophys Acta. 2017 Mar 29;1863(10 Pt A):2414–2435. doi: 10.1016/j.bbadis.2017.03.020

Figure 6.

Figure 6

Chemical structures of the melanocortin ligands used in clinical trials from 2011 to 2016. The ligand MTII is included as a comparison to bremelanotide.